Award details

Structurally modified master seed viruses to enhance conventional foot-and-mouth disease virus vaccine protection

ReferenceBBS/E/I/00001494
Principal Investigator / Supervisor Professor Bryan Charleston
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 35,100
StatusCompleted
TypeInstitute Project
Start date 01/04/2010
End date 31/03/2013
Duration36 months

Abstract

The current FMD vaccines are inactivated whole virus preparations. Despite success in the developed world, two major problems limit their capacity to control infections in developing countries. First, the virus is notoriously unstable, especially for the serotypes O and SAT2. During production the manufacturer has to compensate for this instability, which is expensive and reduces vaccine yield. Also, unstable vaccines are believed to be less immunogenic due to degradation before and after inoculation. In addition, to be effective, FMDV vaccines require frequent booster vaccinations, possibly due to vaccine antigen instability. Secondly, FMDV serotypes can be highly variable, especially serotypes A and SAT2, necessitating frequent development of new vaccine strains. Some viruses have proven very difficult to adapt to cell culture, slowing the manufacturing process, reducing vaccine yield and potentiating the selection of undesired antigenic changes.The main objectives of this proposal are to use reverse genetics to produce and market, on an industrial scale, recombinant FMD viruses with enhanced thermal stability and cell-culture growth. Currently, live recombinant viruses can be recovered and inactivated vaccine produced in the conventional manner. However, the feasibility of applying this technology on an industrial scale has not yet been tested.

Summary

unavailable
Committee Not funded via Committee
Research TopicsAnimal Health, Immunology, Microbiology
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file